SCHEMBL13988148

SCHEMBL13988148

CC(C)[C@@H](C)CC[C@@H](C)[C@H]1CCC2C3CC[C@H]4C[C@@H](O)CC[C@]4(C)C3CC[C@@]21C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 7/20 0.72
▸ EPHA2 P29317 4/20 0.72
▸ CASP7 P55210 3/20 0.72
▸ HIF1A Q16665 3/20 0.72
▸ TP53 P04637 2/20 0.72
▸ MAPK1 P28482 2/20 0.72
▸ HSD17B10 Q99714 2/20 0.72
▸ BLM P54132 2/20 0.72
▸ TDP1 Q9NUW8 2/20 0.72
▸ VDR P11473 2/20 0.72
▸ USP2 O75604 2/20 0.72
▸ LMNA P02545 2/20 0.72
▸ CYP3A4 P08684 2/20 0.72
▸ MDM4 O15151 1/20 0.72
▸ MAPT P10636 1/20 0.72
▸ HSPD1 P10809 1/20 0.72
▸ TSHR P16473 1/20 0.72
▸ PTPN2 P17706 1/20 0.72
▸ PTPN1 P18031 1/20 0.72
▸ BRCA1 P38398 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14116859 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL480834 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL167700 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL14612012 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL14537828 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL24710359 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL15346202 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL21748184 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL21524957 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL14350523 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8486374-B2 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions FOAMIX LTD. (IL) 2013-07-16 — — US disclosed
US-8486374-B2 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions FOAMIX LTD. (IL) 2013-07-16 — — US disclosed
US-20080299220-A1 HYDROPHILIC, NON-AQUEOUS PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.) 2008-12-04 — — US disclosed
US-20080299220-A1 HYDROPHILIC, NON-AQUEOUS PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.) 2008-12-04 — — US disclosed
US-20080292560-A1 SILICONE IN GLYCOL PHARMACEUTICAL AND COSMETIC COMPOSITIONS WITH ACCOMMODATING AGENT FOAMIX PHARMACEUTICALS LTD. (IL) 2008-11-27 — — US disclosed
US-20080206161-A1 QUIESCENT FOAMABLE COMPOSITIONS, STEROIDS, KITS AND USES THEREOF FOAMIX PHARMACEUTICALS LTD. (IL) 2008-08-28 — — US disclosed
US-20080063607-A1 Oleaginous pharmaceutical and cosmetic foam FOAMIX LTD 2008-03-13 — — US disclosed
US-20080063607-A1 Oleaginous pharmaceutical and cosmetic foam FOAMIX LTD 2008-03-13 — — US disclosed
US-20070292461-A1 Oleaginous pharmaceutical and cosmetic foam FOAMIX LTD. (IL) 2007-12-20 — — US disclosed
US-20070292461-A1 Oleaginous pharmaceutical and cosmetic foam FOAMIX LTD. (IL) 2007-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080206161-A1 QUIESCENT FOAMABLE COMPOSITIONS, STEROIDS, KITS AND USES THEREOF NR5A1, CYP17A1, LIPA GPBAR1 1050/4885EPHA2 1840/4885CASP7 1048/4885
US-20080292560-A1 SILICONE IN GLYCOL PHARMACEUTICAL AND COSMETIC COMPOSITIONS WITH ACCOMMODATING AGENT SSTR2, SSTR3, LPXN GPBAR1 2291/4885EPHA2 3969/4885CASP7 2131/4885
US-20070292461-A1 Oleaginous pharmaceutical and cosmetic foam LIPA, LIPC, PLIN3 GPBAR1 824/4885EPHA2 3276/4885CASP7 2186/4885
US-20080063607-A1 Oleaginous pharmaceutical and cosmetic foam LIPA, LIPC, PLIN3 GPBAR1 824/4885EPHA2 3276/4885CASP7 2186/4885
US-20080299220-A1 HYDROPHILIC, NON-AQUEOUS PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES LIPA, PHOSPHO1, MYO1G GPBAR1 1619/4885EPHA2 615/4885CASP7 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback